Sorrento Therapeutics, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Glasgow United Kingdom (1999)

Organization Overview

First Clinical Trial
2008
NCT00804154
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Sorrento Therapeutics | Sorrento Therapeutics, Inc. | Virttu Biologics Limited